Characteristics | Thiele, 2015 [4]a | Mikuls, 2018 [18] | Mikuls, 2020 [8] | Petro, 2021 [23] | Grönwall, 2021 [6] | de Moel, 2023 [5] NLD/FNS/JPN/SA | Santiago | Barcelona |
---|---|---|---|---|---|---|---|---|
Number of patients | 1720 | 284 | 214 | 1229 | 403 | 103/100/174/67 | 517 | 178 |
IgG anti-MAA+, % | 92 | 80 | 22 | 67 | 44 | 29/29/22/53b | 6 | 7 |
European, % | 78 | 75 | 58 | 89 | 100 | 100/0/0/0 | 100 | 100 |
African, % | 16 | 17 | Yesc | 6 | 0 | 0/0/0/100 | 0 | 0 |
Age, mean (SD) | 63 (11) | 59 (12) | 37 (8)d | 57 (13) | 50 (13) | 58/48/60/49e | 61 (14) | 59 (13) |
Women, % | 9 | 37 | 48 | 79 | 70 | 66/79/82/89 | 77 | 79 |
Ever smokers, % | 80 | 62f | 33 | 52 | 72 | 60/84/28/12 | 20 | 46 |
Military, predominantly | Yes | Yes | Yes | No | No | No | No | No |
anti-CCP+, % | 78 | 85f | 71 | 55 | 69 | 100 | 64 | 71 |
IgG anti-MAA+/anti-CCP+, % | 93 | 83 | 22b | 74 | 49 | 29/29/22/53b | 5 | 7 |
Percentile IgG anti-MAAg | 99 | 95 | 90 | (67)g | 85 | 97.5 g | 98 | 95 |
Years with RA, mean (SD) | 12 (12) | 13 (10)f | 7 (4) | - | 1 h | 1.3/7.7/7.5/0e | 14 (11) | 6 (5) |